Загрузка...
Opportunities in immunotherapy of ovarian cancer
Ovarian cancer (OC) is the most important cause of gynecological cancer-related mortality, with the majority of women presenting with advanced disease. Although surgery and chemotherapy can improve survival, the 5-year survival rates remain ominously low at 45%. Novel therapies are urgently needed....
Сохранить в:
| Опубликовано в: : | Ann Oncol |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4852275/ https://ncbi.nlm.nih.gov/pubmed/27141063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw084 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|